MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jtha.2024.01.019

Медицинская библиотека · Journal of thrombosis and haemostasis : JTH · 2024

Natural history of cancer-associated splanchnic vein thrombosis.

Shang Hanqing, Jiang Jun Y, Guffey Danielle, Novoa Francisco, Bandyo Raka, Ma Shengling, Li Ang

СтатьяПоддержка NIH: внешняя программаМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

There is uncertainty in the management of cancer-associated isolated splanchnic vein thrombosis (SpVT).

OBJECTIVES

To describe the natural history of SpVT by cancer type and thrombus composition and to review anticoagulation (AC) practices and associated rates of usual-site venous thromboembolism (VTE), major and clinically relevant nonmajor bleeding (MB/CRNMB), recanalization/progression, and mortality.

METHODS

We performed a retrospective cohort study in patients with SpVT at 2 cancer care centers in Houston, Texas. We estimated the incidence of usual-site VTE and MB/CRNMB at 6 months using competing risk methods and examined venous patency in a subset of patients with repeat imaging. We assessed associations with mortality using Cox regression.

RESULTS

Among 15 342 patients with an incident cancer diagnosis from 2011 to 2020, we identified 298 with isolated SpVT. Patients with hepatocellular carcinoma (HCC) and SpVT (n = 146) had the highest disease prevalence (20%), lowest rate of AC treatment (2%), and similar rate of usual-site VTE (4.2%) vs those without SpVT (5.2%) at 6 months, though tumor thrombus vs bland was associated with worse overall survival. In patients with non-HCC bland SpVT (n = 114), AC (n = 37) was more common in those with non-upper gastrointestinal cancers and fewer comorbidities. AC was associated with more recanalization (44% vs 15%, P = .041) but no differences in usual-site VTE, MB/CRNMB, or mortality at 6 months.

CONCLUSION

Cancer-associated isolated SpVT is a common but heterogeneous thrombotic disease that is treated differently from usual-site VTE. Tumor thrombus is a negative prognostic factor. Initiation of AC in bland thrombi requires judicious consideration of thrombotic and bleeding risk.

Для цитирования: Shang Hanqing, Jiang Jun Y, Guffey Danielle, Novoa Francisco, Bandyo Raka, Ma Shengling, Li Ang. Natural history of cancer-associated splanchnic vein thrombosis.. Journal of thrombosis and haemostasis : JTH. 2024. DOI: 10.1016/j.jtha.2024.01.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.